1. Home
  2. CCCC vs ACR Comparison

CCCC vs ACR Comparison

Compare CCCC & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • ACR
  • Stock Information
  • Founded
  • CCCC 2015
  • ACR 2005
  • Country
  • CCCC United States
  • ACR United States
  • Employees
  • CCCC N/A
  • ACR N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • ACR Real Estate Investment Trusts
  • Sector
  • CCCC Health Care
  • ACR Real Estate
  • Exchange
  • CCCC Nasdaq
  • ACR Nasdaq
  • Market Cap
  • CCCC 160.1M
  • ACR 143.3M
  • IPO Year
  • CCCC 2020
  • ACR N/A
  • Fundamental
  • Price
  • CCCC $2.46
  • ACR $19.33
  • Analyst Decision
  • CCCC Strong Buy
  • ACR Buy
  • Analyst Count
  • CCCC 4
  • ACR 2
  • Target Price
  • CCCC $8.50
  • ACR $23.50
  • AVG Volume (30 Days)
  • CCCC 2.9M
  • ACR 17.9K
  • Earning Date
  • CCCC 11-03-2025
  • ACR 10-29-2025
  • Dividend Yield
  • CCCC N/A
  • ACR N/A
  • EPS Growth
  • CCCC N/A
  • ACR N/A
  • EPS
  • CCCC N/A
  • ACR 0.04
  • Revenue
  • CCCC $34,240,000.00
  • ACR $86,599,000.00
  • Revenue This Year
  • CCCC N/A
  • ACR $7.03
  • Revenue Next Year
  • CCCC N/A
  • ACR $3.26
  • P/E Ratio
  • CCCC N/A
  • ACR $465.65
  • Revenue Growth
  • CCCC 16.55
  • ACR 12.74
  • 52 Week Low
  • CCCC $1.09
  • ACR $14.87
  • 52 Week High
  • CCCC $6.52
  • ACR $23.81
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 51.01
  • ACR 34.40
  • Support Level
  • CCCC $2.31
  • ACR $18.99
  • Resistance Level
  • CCCC $2.82
  • ACR $20.80
  • Average True Range (ATR)
  • CCCC 0.22
  • ACR 0.51
  • MACD
  • CCCC 0.03
  • ACR -0.17
  • Stochastic Oscillator
  • CCCC 52.41
  • ACR 17.26

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: